El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
Klippel–Trenaunay syndrome is an uncommon genetic condition. The main pathology consists of arteriovenous malformations. It is generally asymptomatic but may present as soft tissue or bony hypertrophy. We hereby present a case of Klippel–Trenaunay syndrome of an 18 year old male patient coming with large venous malformations, lymphangiomas and A-V fistula at lower leg along with soft tissue hypertrophy of right foot. Patient was evaluated clinically and radiologically and a diagnosis of Klippel–Trenaunay syndrome was formed. Patient was given compression stockings and asked to followup regularly.
based on a review article published in 'seminars in nuclear medicine' 2020
compiled by Dr Bela Jain and Dr Amitabh Arya, Department of Nuclear Medicine, SGPGI, Lucknow, India
Extramedullary Hematopoiesis (EMH) is a compensatory mechanism in response to ineffective hematopoiesis or stress erythropoiesis, in sites other than the bone marrow. The EMH often presents as pseudotumors and may be confused with other benign or malignant tumors. The cause of EMH often
is an underlying hematopoietic disorder, and it may be adequately treated by treating the underlying cause. This will avoid unnecessary surgical interventions. Hence, knowledge of this entity is of utmost importance, and careful history, clinical examination and necessary investigations must be carried out
before deciding the course of therapy.
Slideshow is from the University of Michigan Medical
School's M2 Hematology / Oncology sequence
View additional course materials on Open.Michigan: openmi.ch/med-M2Hematology
Klippel–Trenaunay syndrome is an uncommon genetic condition. The main pathology consists of arteriovenous malformations. It is generally asymptomatic but may present as soft tissue or bony hypertrophy. We hereby present a case of Klippel–Trenaunay syndrome of an 18 year old male patient coming with large venous malformations, lymphangiomas and A-V fistula at lower leg along with soft tissue hypertrophy of right foot. Patient was evaluated clinically and radiologically and a diagnosis of Klippel–Trenaunay syndrome was formed. Patient was given compression stockings and asked to followup regularly.
based on a review article published in 'seminars in nuclear medicine' 2020
compiled by Dr Bela Jain and Dr Amitabh Arya, Department of Nuclear Medicine, SGPGI, Lucknow, India
Extramedullary Hematopoiesis (EMH) is a compensatory mechanism in response to ineffective hematopoiesis or stress erythropoiesis, in sites other than the bone marrow. The EMH often presents as pseudotumors and may be confused with other benign or malignant tumors. The cause of EMH often
is an underlying hematopoietic disorder, and it may be adequately treated by treating the underlying cause. This will avoid unnecessary surgical interventions. Hence, knowledge of this entity is of utmost importance, and careful history, clinical examination and necessary investigations must be carried out
before deciding the course of therapy.
Slideshow is from the University of Michigan Medical
School's M2 Hematology / Oncology sequence
View additional course materials on Open.Michigan: openmi.ch/med-M2Hematology
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...Fundación Ramón Areces
El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
Víctor Martínez-Glez. - Instituto de Genética Médica y Molecular (INGEMM). I...Fundación Ramón Areces
El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
These are diseases for which transplants of blood-forming stem cells (Hematopoietic Stem Cell Transplants, HSCT) are a standard treatment. For some diseases they are the only therapy, and in other diseases they are only employed when front-line therapies have failed or the disease is very aggressive. For more info visit: http://www.cryobanksindia.com/moms-corner/case-studies/
Jordi Torren - Coordinador del proyecto ESVAC. Agencia Europea de Medicamento...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
Dominique L. Monnet Director del programa ARHAI (Antimicrobial Resistance an...Fundación Ramón Areces
El martes 5 de junio del 2018 organizamos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre el consumo de antibióticos y transmisión de resistencia entre humanos y animales.
El jueves 24 de mayo del 2018 organizamos una Conferencia con Antonio Cabrales en la Fundación Ramón Areces. Una conferencia en la cual el tema fue: Estilo negociador y confianza, ¿hay diferencias entre hombres y mujeres?
Teresa Puig - Institut de Ciència de Materials de Barcelona, ICMAB-CSIC, Espa...Fundación Ramón Areces
El lunes y martes 21 y 22 de mayo del 2018 realizamos un Simposio Internacional en la Fundación Ramón Areces, tratando el tema de la superconductividad y presión: una relación fructífera en el camino hacia la superconductividad a temperatura ambiente.
Elena Bascones - Instituto de Ciencia de Materiales de Madrid (ICMM-CSIC), Es...Fundación Ramón Areces
El lunes y martes 21 y 22 de mayo del 2018 realizamos un Simposio Internacional en la Fundación Ramón Areces, tratando el tema de la superconductividad y presión: una relación fructífera en el camino hacia la superconductividad a temperatura ambiente.
El jueves 17 de mayo del 2018 se organizó una Mesa Redonda en la Fundación Ramón Areces, en la cual se habló sobre las subidas de tipos en la era Trump y la nueva globalización.
El jueves 17 de mayo del 2018 se organizó una Mesa Redonda en la Fundación Ramón Areces, en la cual se habló sobre las subidas de tipos en la era Trump y la nueva globalización.
El miércoles 16 de mayo del 2018 celebramos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre las nuevas fronteras de investigación sobre la distribución comercial y el comportamiento del consumidor.
El miércoles 16 de mayo del 2018 celebramos una Jornada en la Fundación Ramón Areces, en la cual se habló sobre las nuevas fronteras de investigación sobre la distribución comercial y el comportamiento del consumidor.
Rudolf Happle - Dermatología, University of Freiburg Medical Center, Freiburg...Fundación Ramón Areces
El jueves y viernes 10 y 11 de mayo del 2018 realizamos en la Fundación Ramón Areces un Simposio Internacional, en el cual se trató el tema del mosaicismo somático en malformaciones vasculares.
Rafael Doménech - Responsable de Análisis Macroeconómico, BBVA Research. Fundación Ramón Areces
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
Nicholas Barr - Profesor de Economía Pública, London School of Economics. Fundación Ramón Areces
El martes 8 de mayo de 2018 realizamos una conferencia en la Fundación Ramón Areces, en la cual se habló sobre el futuro de las pensiones: una visión global.
El viernes 27 de abril del 2018 se celebró en la Fundación Ramón Areces una Jornada sobre física , en la cual se trataron diversos temas como: Los materiales mecanocalóricos, magnetísmo, biofísica, la energía oscura y instrumentación astronómica.
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
Marta Olivares - Investigadora Postdoctoral en Université catholique de Louva...Fundación Ramón Areces
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
Víctor R. de la Rosa - Investigador en Universiteit Gent (UGent) y fundador d...Fundación Ramón Areces
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
El viernes 20 de abril organizamos una Jornada sobre la ciencia en el corazón de Europa, en colaboración con Científicos Españoles en Bélgica (CEBE) y realizada en la Fundación Ramón Areces.
Seminar of U.V. Spectroscopy by SAMIR PANDASAMIR PANDA
Spectroscopy is a branch of science dealing the study of interaction of electromagnetic radiation with matter.
Ultraviolet-visible spectroscopy refers to absorption spectroscopy or reflect spectroscopy in the UV-VIS spectral region.
Ultraviolet-visible spectroscopy is an analytical method that can measure the amount of light received by the analyte.
This pdf is about the Schizophrenia.
For more details visit on YouTube; @SELF-EXPLANATORY;
https://www.youtube.com/channel/UCAiarMZDNhe1A3Rnpr_WkzA/videos
Thanks...!
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Earliest Galaxies in the JADES Origins Field: Luminosity Function and Cosmic ...Sérgio Sacani
We characterize the earliest galaxy population in the JADES Origins Field (JOF), the deepest
imaging field observed with JWST. We make use of the ancillary Hubble optical images (5 filters
spanning 0.4−0.9µm) and novel JWST images with 14 filters spanning 0.8−5µm, including 7 mediumband filters, and reaching total exposure times of up to 46 hours per filter. We combine all our data
at > 2.3µm to construct an ultradeep image, reaching as deep as ≈ 31.4 AB mag in the stack and
30.3-31.0 AB mag (5σ, r = 0.1” circular aperture) in individual filters. We measure photometric
redshifts and use robust selection criteria to identify a sample of eight galaxy candidates at redshifts
z = 11.5 − 15. These objects show compact half-light radii of R1/2 ∼ 50 − 200pc, stellar masses of
M⋆ ∼ 107−108M⊙, and star-formation rates of SFR ∼ 0.1−1 M⊙ yr−1
. Our search finds no candidates
at 15 < z < 20, placing upper limits at these redshifts. We develop a forward modeling approach to
infer the properties of the evolving luminosity function without binning in redshift or luminosity that
marginalizes over the photometric redshift uncertainty of our candidate galaxies and incorporates the
impact of non-detections. We find a z = 12 luminosity function in good agreement with prior results,
and that the luminosity function normalization and UV luminosity density decline by a factor of ∼ 2.5
from z = 12 to z = 14. We discuss the possible implications of our results in the context of theoretical
models for evolution of the dark matter halo mass function.
Nutraceutical market, scope and growth: Herbal drug technologyLokesh Patil
As consumer awareness of health and wellness rises, the nutraceutical market—which includes goods like functional meals, drinks, and dietary supplements that provide health advantages beyond basic nutrition—is growing significantly. As healthcare expenses rise, the population ages, and people want natural and preventative health solutions more and more, this industry is increasing quickly. Further driving market expansion are product formulation innovations and the use of cutting-edge technology for customized nutrition. With its worldwide reach, the nutraceutical industry is expected to keep growing and provide significant chances for research and investment in a number of categories, including vitamins, minerals, probiotics, and herbal supplements.
Professional air quality monitoring systems provide immediate, on-site data for analysis, compliance, and decision-making.
Monitor common gases, weather parameters, particulates.
Juan Carlos López-Gutiérrez - Unidad de Anomalías Vasculares, Hospital Universitario La Paz. Madrid, España.
1. Clinical Classification of Vascular Anomalies
Controversies and recent advances
Juan Carlos Lopez Gutierrez
Vascular Anomalies Center
La Paz Children´s Hospital
Simposio Internacional: Mosaicismo somático en malformaciones vasculares. Madrid, 10 y 11 de mayo de 2018
2.
3. In 2018 , 50.000 children are expected to need treatment for a
Vascular Anomaly in Europe
4.
5. ISSVA classification for vascular anomalies
(Approved at the 20th ISSVA Workshop, Melbourne, April 2014)
Overview table
°defined as two or more vascular malformations found in one lesion
* high-flow lesions
N.B. The classification tables do not list exhaustively all known vascular anomalies.
Some rare "dermatologic" vascular anomalies will be found in dermatology textbooks.
The tumor or malformation nature or precise classification of some lesions is still unclear.
These lesions appear in a separate provisional list.
Vascular anomalies
Vascular tumors Vascular malformations
Simple Combined °
of major named
vessels
associated with
other anomalies
Benign
Locally aggressive or
borderline
Malignant
Capillary malformations
Lymphatic malformations
Venous malformations
Arteriovenous malformations*
Arteriovenous fistula*
CVM, CLM
LVM, CLVM
CAVM*
CLAVM*
others
See details See list
For more details, click on
the underlined linksAbbreviations used
6. ISSVA classification of vascular tumors I
Benign vascular tumors
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma
Rapidly involuting (RICH) *, Non-involuting (NICH), Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma
Pyogenic granuloma (aka lobular capillary hemangioma)
Others
Hobnail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt
for previous
view
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
7. Benign vascular tumors
Congenital hemangioma GNAQ / GNA11
Rapidly involuting (RICH)
Non-involuting (NICH)
Partially involuting (PICH)
Tufted angioma GNA14
Epithelioid hemangioma FOS
Pyogenic granuloma BRAF / RAS / GNA14
Spindle-cell hemangioma IDH1 / IDH2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma t(13;16)(q14;p13.3) GNA14
Pseudomyogenic hemangioendothelioma t(7:19)(q22;13) / FOSB
Malignant vascular tumors
Angiosarcoma (post radiation) MYC
Epithelioid hemangioendothelioma CAMTA1 / TFE3
Back to
overview
Type Alt
for previous
viewAppendix 2-a
causal genes of vascular anomalies
8. Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) GNAQ
CM with bone and/or soft tissue hyperplasia GNA11
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) GNAQ
CM of CM-AVM RASA1 / EPHB4
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT)
HHT1 ENG
HHT2 ACVRL1
HHT3
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch
Others
Appendix 2-b
causal genes of vascular anomalies
Back to
overview
Type Alt
for previous
view
9. Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM PIK3CA somatic
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
Acquired progressive lymphatic anomaly (acquired progressive "lymphangioma")
Others
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt
for previous
viewAppendix 2-c
causal genes of vascular anomalies
10. Lymphatic malformations (LM)
Primary lymphedema
Nonne-Milroy syndrome
FLT4 / VEGFR3
Primary hereditary lymphedema VEGFC
Primary hereditary lymphedema GJC2 / Connexin 47
Lymphedema-distichiasis FOXC2
Hypotrichosis-lymphedema-telangiectasia SOX18
Primary lymphedema with myelodysplasia GATA2
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) CCBE1
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome KIF11
Lymphedema-choanal atresia PTPN14
Back to
overview Appendix 2-d
causal genes of vascular anomalies
Type Alt
for previous
view
11. Venous malformations (VM)
Common VM TEK (TIE2) / PIK3CA somatic
Familial VM cutaneo-mucosal (VMCM) TEK (TIE2)
Blue rubber bleb nevus (Bean) syndrome VM TEK (TIE2) somatic
Glomuvenous malformation (VM with glomus cells) Glomulin
Cerebral cavernous malformation (CCM)
CCM1 KRIT1
CCM2 Malcavernin
CCM3 PDCD10
Familial intraosseous vascular malformation (VMOS) ELMO2
Back to
overview Appendix 2-e
causal genes of vascular anomalies
Type Alt
for previous
view
12. Arteriovenous malformations (AVM)
Sporadic MAP2K1
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hem. telangiect.) SMAD4
In CM-AVM RASA1 / EPHB4
Arteriovenous fistulas (AVF)
Sporadic MAP2K1
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
In CM-AVM RASA1 / EPHB4
Back to
overview Appendix 2-f
causal genes of vascular anomalies
Abbreviations used
Type Alt
for previous
view
13. Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome PIK3CA somatic
Parkes Weber syndrome RASA1
Servelle-Martorell syndrome
Sturge-Weber syndrome GNAQ
Limb CM + congenital non-progressive limb overgrowth GNA11
Maffucci syndrome IDH1 / IDH2
Macrocephaly - CM (M-CM or MCAP) PIK3CA
Microcephaly - CM (MICCAP) STAMBP
CLOVES syndrome PIK3CA somatic
Proteus syndrome AKT1
Bannayan-Riley-Ruvalcaba syndrome PTEN
CLAPO syndrome PIK3CA
Appendix 2-g
causal genes of vascular anomalies
Abbreviations used
Type Alt
for previous
view
14. Provisionally unclassified vascular anomalies
Verrucous hemangioma / Verrucous VM / Verrucous LVM MAP3K3 somatic
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue PTEN
Fibro adipose vascular anomaly (FAVA) PIK3CA
Back to
overview Appendix 2 -h
causal genes of vascular anomalies
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt
for previous
view
15. Appendix 3
infantile hemangioma
Back to
overview
Pattern
- focal
- multifocal
- segmental
- indeterminate
Different types
- superficial
- deep
- mixed (superficial + deep)
- reticular / abortive / minimal growth
- others
Association with other lesions
PHACE association /
syndrome
Posterior fossa malformations, Hemangioma, Arterial
anomalies, Cardiovascular anomalies, Eye anomalies,
sternal clefting and ⁄ or supraumbilical raphe
LUMBAR (SACRAL,
PELVIS) association /
syndrome
Lower body hemangioma, Urogenital anomalies,
Ulceration, Myelopathy, Bony deformities, Anorectal
malformations, Arterial anomalies, and Renal anomalies
Type Alt
for previous
view
22. The United Network for Organ Sharing (UNOS) database recorded that a total of 35 children under 1 year of
age underwent liver transplantation between 1989 and 2008, because of hemangioma. In contrast, between
2009 and 2017, among 2672 children aged less than 1 year who underwent liver transplantation, none had a
diagnosis of hemangioma
28. ISSVA classification of vascular tumors II or 2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma * °
Retiform hemangioendothelioma
Papillary intralymphatic angioendothelioma (PILA), Dabska tumor
Composite hemangioendothelioma
Pseudomyogenic hemangioendothelioma G
Polymorphous hemangioendothelioma
Hemangioendothelioma not otherwise specified
Kaposi sarcoma
Others
Malignant vascular tumors
Angiosarcoma G
Epithelioid hemangioendothelioma G
Others
Back to
overview
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
Type Alt
for previous
view
31. The spectrum of disease varies greatly between
an indolent disease and aggressive disease with
widespread metastases.
Doyle LA, Fletcher CD, Hornick JL.Nuclear Expression of CAMTA1
Distinguishes Epithelioid Hemangioendothelioma From Histologic
Mimics. Am J Surg Pathol.2016 Jan;40(1):94-102
Uncertain biological behaviour of Composite , Retiform, Epithelioid Hemagioendotheliomas
38. Similar clinical course in Pediatric and Adult EHE ?
Similar clinical course in liver , skin or pulmonary EHE?
Literature review identified 24 children with EHE of the liver/lungs.
Most presented with multifocal, systemic disease.
Four children experienced rapid progression and died.
In six children, disease remained stable for years without therapy.
Two patients died from progressive EHE 21 and 24 years after first
diagnosis.
Twelve surgically excised are free of disease
Natural evolution of pediatric visceral EHE is variable, and long-term
prognosis remains unclear
Hettmer S et al.
Epithelioid hemangioendotheliomas of the liver and lung in children and adolescents.
Pediatr Blood Cancer.2017 Dec;64(12)
39. Simple vascular malformations I
Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) G
CM with bone and/or soft tissue overgrowth G
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome)
CM of CM-AVM G
CM of MICCAP (microcephaly-capillary malformation)
CM of MCAP (megalencephaly-capillary malformation-polymicrogyria)
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) (different types) G
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch / “angel kiss”, “stork bite”
Others
ISSVA classification for vascular anomaliesBack to
overview
clic on G to see genetics
Type Alt
for previous
view
44. No seizures after 1 year under Sirolimus-AAS treatment
Better than expected response to Pulse Dye Laser treatment
MOST SEVERE PRESENTATION OF STURGE WEBER SME.
45. Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM G
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
ISSVA classification for vascular anomalies
46.
47. Infiltration ? Invasion ? Proliferation ? Growth? Enlargement?
Dilatation ?
“Lymphangiomatosis is a rare disease characterized by diffuse infiltration of lymphangiomas in the lung,
bone, and other tissues………”
“Diffuse pulmonary lymphangiomatosis has a poor prognosis and is characterized by slow progressive
growth of lymphatic……..”
“Disseminated lymphangiomatosis is a rare vascular tumor characterized by a proliferation of abnormal
lymphatic channels that often involves multiple organ systems………………..”
“However, diffuse pulmonary lymphangiomatosis may present as a form of lymphangiectasia, which is
characterized pathologically as dilatations of lymphatics without proliferation and without an
anastomosing pattern……………………..”
48. AGRESSIVE LYMPHATIC MALFORMATIONS: A PROLIFERATIVE DISORDER ?
Meijer-Jorna LB et al. Microvascular proliferation in congenital vascular
malformations of skin and soft tissue J Clin Pathol. 2007 July; 60(7):
798–803.
“Proliferation does not happen in LM…….”
The presence of presumed lymphatic channels in bone that is either hypertrophic or
shows progressive disappearance is not associated with increased levels of cell
turnover or osteocyte activity ( Paula North, 1st GLA-GSD Conference.Bethesda 2013)
60. Simple vascular malformations IIb
Primary lymphedema
Nonne-Milroy syndrome G
Primary hereditary lymphedema G
Lymphedema-distichiasis G
Hypotrichosis-lymphedema-telangiectasia G
Primary lymphedema with myelodysplasia G
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) G
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome G
Lymphedema-choanal atresia G
Back to
overview ISSVA classification for vascular anomalies
clic on G to see genetics
Type Alt
for previous
view
65. Simple vascular malformations III
Venous malformations (VM)
Common VM G
Familial VM cutaneo-mucosal (VMCM) G
Blue rubber bleb nevus (Bean) syndrome VM G
Glomuvenous malformation (GVM) G
Cerebral cavernous malformation (CCM) (different types) G
Familial intraosseous vascular malformation (VMOS) G
Others
ISSVA classification for vascular anomalies
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt
for previous
view
66.
67. Caso 1Lopez Gutierrez JC , Ivars M. Fern-shaped patch as a hallmark of blue rubber
bleb nevus syndrome in neonatal venous malformations
Eur J Pediatr. 2018 Mar 8.
71. Simple vascular malformations IV
Arteriovenous malformations (AVM)
Sporadic
In HHT G
In CM-AVM G
Others
Arteriovenous fistula (AVF) (congenital)
Sporadic
In HHT G
In CM-AVM G
Others
ISSVA classification for vascular anomalies
Back to
overview
Abbreviations used clic on G to see genetics
Type Alt
for previous
view
72.
73.
74.
75. Girón-Vallejo O, López-Gutiérrez JC, Fernández-Pineda I
Diagnosis and treatment of Parkes Weber syndrome: a review of 10 consecutive patients.
Ann Vasc Surg.2013 Aug;27(6):820-5.
80. ISSVA classification for vascular anomalies
Combined vascular malformations*
CM + VM capillary-venous malformation CVM
CM + LM capillary-lymphatic malformation CLM
CM + AVM capillary-arteriovenous malformation CAVM
LM + VM lymphatic-venous malformation LVM
CM + LM + VM capillary-lymphatic-venous malformation CLVM
CM + LM + AVM capillary-lymphatic-arteriovenous malformation CLAVM
CM + VM + AVM capillary-venous-arteriovenous malformation CVAVM
CM + LM + VM + AVM capillary-lymphatic-venous-arteriovenous m. CLVAVM
Back to
overview
Abbreviations used
* defined as two or more vascular malformations found in one lesion
Type Alt
for previous
view
81. MECHANISMS OF SKELETAL HYPERTROPHY OR ATROPHY IN COMBINED VASCULAR
MALFORMATIONS REMAIN UNEXPLAINED
Patients with PIK3CA mutations can develope overgrowth, simmetry and undergrowth
85. ORAL PREPARATION FOR CHILDREN UNDER 35 KGS
0’05mg/kg/ 12h
0’4mgs/ml Solution
2´5 mgs tablet in 60ml 5% glucose
86. ISSVA classification for vascular anomalies
Back to
overview
Anomalies of major named vessels
(aka "channel type" or "truncal" vascular malformations)
Affect
lymphatics
veins
arteries
Anomalies of
origin
course
number
length
diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm)
valves
communication (AVF)
persistence (of embryonal vessel)
Abbreviations used
Type Alt
for previous
view
87. TGF-β signaling is upregulated in many elastic fiber diseases including Loeys–Dietz, Marfan, and several
cutis laxa syndromes but the exact spatio-temporal regulation of TGF-β signaling remains a matter of
debate
90. ISSVA classification for vascular anomalies
Provisionally unclassified vascular anomalies
Verrucous hemangioma, V venous malformation, V veno lymphatic malformation G
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue (PHOST) G
Fibro adipose vascular anomaly (FAVA) G
Back to
overview
clic on G to see genetics
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt
for previous
view
96. CONCLUSIONS
Appropiate classification of a VA remains the best way to achieve the
expected therapeutical outcome
Multidisciplinary interpretation of findings from diagnostic
examinations is mandatory and will improve final results
A sense of wonder must guide research by the vascular anomalies
specialist as many entities remain to be identified , classified and
diagnosed.
97. ISSVA classification for vascular anomalies
Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome: CM + VM +/- LM + limb overgrowth G
Parkes Weber syndrome: CM + AVF + limb overgrowth G
Servelle-Martorell syndrome: limb VM + bone undergrowth
Sturge-Weber syndrome: facial + leptomeningeal CM + eye anomalies
+/- bone and/or soft tissue overgrowth G
Limb CM + congenital non-progressive limb hypertrophy G
Maffucci syndrome: VM +/- spindle-cell hemangioma + enchondroma G
Macrocephaly - CM (M-CM / MCAP) G
Microcephaly - CM (MICCAP) G
CLOVES syndrome: LM + VM + CM +/- AVM + lipomatous overgrowth G
Proteus syndrome: CM, VM and/or LM + asymmetrical somatic overgrowth G
Bannayan-Riley-Ruvalcaba sd: AVM + VM +macrocephaly, lipomatous overgrowth G
CLAPO syndrome: lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
Abbreviations used clic on G to see genetics
Type Alt
for previous
view
98. ISSVA classification for vascular anomalies
Provisionally unclassified vascular anomalies
Verrucous hemangioma, V venous malformation, V veno lymphatic malformation G
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue (PHOST) G
Fibro adipose vascular anomaly (FAVA) G
Back to
overview
clic on G to see genetics
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt
for previous
view
99.
100.
101. Yang CH
Orthotopic liver transplant for
multifocal lymphangioendotheliomatosis with
thrombocytopenia.
Pediatr Transplant.2016 May;20(3):456-459.
102. Appendix 4
vascular anomalies
possibly associated with platelet count / coagulation disorders
Back to
overview
Anomalies Hematological disorders
Tufted angioma
Kaposiform hemangioendothelioma
Profound and sustained thrombocytopenia with profound
hypofibrinogenemia, consumptive coagulopathy and
elevated D-dimer (Kasabach-Merritt phenomenon)
Rapidly involuting congenital
hemangioma
Transient mild/moderate thrombocytopenia, +/-
consumptive coagulopathy and elevated D-dimer
Venous malformations /
Lymphatic-venous malformations
Chronic localized intravascular coagulopathy with
elevated D-dimer, +/- hypofibrinogenemia, and +/-
moderate thrombocytopenia
(may progress to DIC after trauma or operation)
Lymphatic malformations Chronic localized intravascular coagulopathy with
elevated D-dimer and +/- mild to moderate
thrombocytopenia
(consider Kaposiform lymphangiomatosis)
(may progress to DIC after trauma or operation)
Multifocal lymphangioendotheliomatosis
with thrombocytopenia /
Cutaneovisceral angiomatosis with
thrombocytopenia
Sustained, fluctuating, moderate to profound
thrombocytopenia with gastrointestinal tract bleeding or
pulmonary hemorrhage
Kaposiform lymphangiomatosis Mild to Moderate thrombocytopenia, +/-
hypofibrinogenemia, and D-dimer elevation
Type Alt
for previous
view
103. Appendix 1
abbreviations used
(excluding gene names)
Back to
overview
AVF arteriovenous fistula
AVM arteriovenous malformation
CAT cutaneovisceral angiomatosis with thrombocytopenia
CAVM capillary arteriovenous malformation
CCM cerebral cavernous malformation
CLAVM capillary lymphatic arteriovenous malformation
CLAPO
lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
CLOVES
congenital lipomatous overgrowth, vascular
malformations, epidermal nevi, skeletal/scoliosis and
spinal abnormalities
CLM capillary lymphatic malformation
CLVAVM capillary lymphatic venous arteriovenous malformation
CLVM capillary lymphatic venous malformation
CM capillary malformation
CM-AVM capillary malformation-arteriovenous malformation
CMTC cutis marmorata telangiectatica congenita
CNS central nervous system
CVAVM capillary venous arteriovenous malformation
CVM capillary venous malformation
DIC disseminated intravascular coagulopathy
FAVA Fibro adipose vascular anomaly
GLA generalized lymphatic anomaly
GSD Gorham-Stout disease
GVM glomuvenous malformation
HHT hereditary hemorrhagic telangiectasia
HI hemangioma of infancy / infantile hemangioma
IH infantile hemangioma / hemangioma of infancy
INR international normalized ratio
JPHT juvenile polyposis hemorrhagic telangiectasia
KHE kaposiform hemangioendothelioma
KLA kaposiform lymphangiomatosis
KMP Kasabach-Merritt phenomenon,
LM lymphatic malformation
LVM lymphatic venous malformation
MCAP megalencephaly-capillary malformation-polymicrogyria
M-CM macrocephaly-capillary malformation
MICCAP microcephaly-capillary malformation
MLT
Multifocal lymphangioendotheliomatosis with
thrombocytopenia
NICH non-involuting congenital hemangioma
PHACE
posterior fossa malformations, hemangioma, arterial
anomalies, cardiovascular anomalies, eye anomalies
PHOST PTEN hamartoma of soft tissue
PILA papillary intralymphatic angioendothelioma
PICH partially involuting congenital hemangioma
RICH rapidly involuting congenital hemangioma
TA tufted angioma
VM venous malformation
VMCM venous malformation cutaneo mucosal
Type Alt
for previous
view
104. Benign vascular tumors
Congenital hemangioma GNAQ / GNA11
Rapidly involuting (RICH) *
Non-involuting (NICH)
Partially involuting (PICH)
Epithelioid hemangioma FOS
Spindle-cell hemangioma IDH1 / IDH2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma t(13;16)(q14;p13.3)
Pseudomyogenic hemangioendothelioma t(7:19)(q22;13) FOSB
Malignant vascular tumors
Angiosarcoma (post radiation) MYC
Epithelioid hemangioendothelioma CAMTA1 / TFE3
Back to
overview
Type Alt
for previous
viewAppendix 2-a
causal genes of vascular anomalies
105. Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) GNAQ
CM with bone and/or soft tissue hyperplasia GNA11
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome) GNAQ
CM of CM-AVM RASA1 / EPHB4
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT)
HHT1 ENG
HHT2 ACVRL1
HHT3
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch
Others
Appendix 2-b
causal genes of vascular anomalies
Back to
overview
Type Alt
for previous
view
106. Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM PIK3CA?
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
Acquired progressive lymphatic anomaly (benign "lymphangioendothelioma")
Others
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt
for previous
viewAppendix 2-c
causal genes of vascular anomalies
107. Lymphatic malformations (LM)
Primary lymphedema
Nonne-Milroy syndrome FLT4 / VEGFR3
Primary hereditary lymphedema VEGFC
Primary hereditary lymphedema GJC2 / Connexin 47
Lymphedema-distichiasis FOXC2
Hypotrichosis-lymphedema-telangiectasia SOX18
Primary lymphedema with myelodysplasia GATA2
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) CCBE1
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome KIF11
Lymphedema-choanal atresia PTPN14
Back to
overview Appendix 2-d
causal genes of vascular anomalies
Type Alt
for previous
view
108. Venous malformations (VM)
Common VM TEK (TIE2) / PIK3CA somatic
Familial VM cutaneo-mucosal (VMCM) TEK (TIE2)
Blue rubber bleb nevus (Bean) syndrome VM TEK somatic
Glomuvenous malformation (VM with glomus cells) Glomulin
Cerebral cavernous malformation (CCM)
CCM1 KRIT1
CCM2 Malcavernin
CCM3 PDCD10
Familial intraosseous vascular malformation (VMOS) ELMO2
Back to
overview Appendix 2-e
causal genes of vascular anomalies
Type Alt
for previous
view
109. Arteriovenous malformations (AVM)
Sporadic
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hem. telangiect.) SMAD4
In CM-AVM RASA1 / EPHB4
Arteriovenous fistulas (AVF)
Sporadic
In HHT
HHT1 ENG
HHT2 ACVRL1
JPHT (juvenile polyposis hemorrhagic telangiectasia) SMAD4
In CM-AVM RASA1 / EPHB4
Back to
overview Appendix 2-f
causal genes of vascular anomalies
Abbreviations used
Type Alt
for previous
view
110. Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome PIK3CA
Parkes Weber syndrome RASA1
Servelle-Martorell syndrome
Sturge-Weber syndrome GNAQ
Limb CM + congenital non-progressive limb overgrowth GNA11
Maffucci syndrome IDH1 / IDH2 / NPM1
Macrocephaly - CM (M-CM or MCAP) PIK3CA
Microcephaly - CM (MICCAP) STAMBP
CLOVES syndrome PIK3CA
Proteus syndrome AKT1
Bannayan-Riley-Ruvalcaba syndrome PTEN
CLAPO syndrome
Appendix 2-g
causal genes of vascular anomalies
Abbreviations used
Type Alt
for previous
view
111. Provisionally unclassified vascular anomalies
Verrucous hemangioma / V venous malformation / V veno lymphatic malformation MAP3K3 somatic
Angiokeratoma
Sinusoidal hemangioma
Acral arteriovenous "tumour"
Multifocal lymphangioendotheliomatosis with thrombocytopenia / cutaneovisceral
angiomatosis with thrombocytopenia (MLT/CAT)
Kaposiform lymphangiomatosis (KLA)
PTEN (type) hamartoma of soft tissue / "angiomatosis" of soft tissue PTEN
Fibro adipose vascular anomaly PIK3CA
Back to
overview Appendix 2 -h
causal genes of vascular anomalies
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
Type Alt
for previous
view
112. * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1a
Benign vascular tumors 1
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma G
Rapidly involuting (RICH) *
Non-involuting (NICH)
Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma G
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma G
Pyogenic granuloma (aka lobular capillary hemangioma)
Others see details
Back to
overview
Type Alt
for previous
view
113. N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1b
Benign vascular tumors 2
Others
Honail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt
for previous
view
114. ISSVA classification for vascular anomalies
(Approved at the 20th ISSVA Workshop, Melbourne, April 2014)
Overview table
°defined as two or more vascular malformations found in one lesion
* high-flow lesions
N.B. The classification tables do not list exhaustively all known vascular anomalies.
Some rare "dermatologic" vascular anomalies will be found in dermatology textbooks.
The tumor or malformation nature or precise classification of some lesions is still unclear.
These lesions appear in a separate provisional list.
Vascular anomalies
Vascular tumors Vascular malformations
Simple Combined °
of major named
vessels
associated with
other anomalies
Benign
Locally aggressive or
borderline
Malignant
Capillary malformations
Lymphatic malformations
Venous malformations
Arteriovenous malformations*
Arteriovenous fistula*
CVM, CLM
LVM, CLVM
CAVM*
CLAVM*
others
See details See list
For more details, click on
the underlined linksAbbreviations used
115. * some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1a
Benign vascular tumors 1
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma G
Rapidly involuting (RICH) *
Non-involuting (NICH)
Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma G
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma G
Pyogenic granuloma (aka lobular capillary hemangioma)
Others see details
Back to
overview
Type Alt
for previous
view
116. N.B. reactive proliferative vascular lesions are listed with benign tumors
ISSVA classification of vascular tumors 1b
Benign vascular tumors 2
Others
Hobnail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt
for previous
view
117. ISSVA classification of vascular tumors I
Benign vascular tumors
Infantile hemangioma / Hemangioma of infancy see details
Congenital hemangioma
Rapidly involuting (RICH) *, Non-involuting (NICH), Partially involuting (PICH)
Tufted angioma * °
Spindle-cell hemangioma
Intramuscular hemangioma (capillary type)
Epithelioid hemangioma
Pyogenic granuloma (aka lobular capillary hemangioma)
Others
Honail hemangioma
Microvenular hemangioma
Anastomosing hemangioma
Glomeruloid hemangioma
Papillary hemangioma
Intravascular papillary endothelial hyperplasia
Cutaneous epitheliod angiomatous nodule
Acquired elastotic hemangioma
Littoral cell hemangioma of the spleen
Related lesions
Eccrine angiomatous hamartoma
Reactive angioendotheliomatosis
Bacillary angiomatosis
Back to
overview
Type Alt
for previous
view
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
118. ISSVA classification of vascular tumors II or 2
Locally aggressive or borderline vascular tumors
Kaposiform hemangioendothelioma * °
Retiform hemangioendothelioma
Papillary intralymphatic angioendothelioma (PILA), Dabska tumor
Composite hemangioendothelioma
Pseudomyogenic hemangioendothelioma G
Polymorphous hemangioendothelioma
Hemangioendothelioma not otherwise specified
Kaposi sarcoma
Others
Malignant vascular tumors
Angiosarcoma G
Epithelioid hemangioendothelioma G
Others
Back to
overview
* some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
°many experts believe that tufted angioma and kaposiform hemangioendothelioma are part of a spectrum
rather than distinct entities
N.B. reactive proliferative vascular lesions are listed with benign tumors
Type Alt
for previous
view
119. Simple vascular malformations I
Capillary malformations (CM)
Cutaneous and/or mucosal CM (aka “port-wine” stain ) G
CM with bone and/or soft tissue overgrowth G
CM with CNS and/or ocular anomalies (Sturge-Weber syndrome)
CM of CM-AVM G
CM of MICCAP (microcephaly-capillary malformation)
CM of MCAP (megalencephaly-capillary malformation-polymicrogyria)
Telangiectasia
Hereditary hemorrhagic telangiectasia (HHT) (different types) G
Others
Cutis marmorata telangiectatica congenita (CMTC)
Nevus simplex / Salmon patch / “angel kiss”, “stork bite”
Others
ISSVA classification for vascular anomaliesBack to
overview
clic on G to see genetics
Type Alt
for previous
view
120. Simple vascular malformations II
Lymphatic malformations (LM)
Common (cystic) LM G
Macrocystic LM
Microcystic LM
Mixed cystic LM
Generalized lymphatic anomaly (GLA)
LM in Gorham-Stout disease
Channel type LM
Primary lymphedema (different types) G
Acquired progressive lymphatic anomaly (benign "lymphangioendothelioma")
Others
ISSVA classification for vascular anomalies
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt
for previous
view
121. Simple vascular malformations IIb
Primary lymphedema
Nonne-Milroy syndrome G
Primary hereditary lymphedema G
Lymphedema-distichiasis G
Hypotrichosis-lymphedema-telangiectasia G
Primary lymphedema with myelodysplasia G
Primary generalized lymphatic anomaly
(Hennekam lymphangiectasia-lymphedema syndrome) G
Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation syndrome G
Lymphedema-choanal atresia G
Back to
overview ISSVA classification for vascular anomalies
clic on G to see genetics
Type Alt
for previous
view
122. Simple vascular malformations III
Venous malformations (VM)
Common VM G
Familial VM cutaneo-mucosal (VMCM) G
Blue rubber bleb nevus (Bean) syndrome VM G
Glomuvenous malformation (GVM) G
Cerebral cavernous malformation (CCM) (different types) G
Familial intraosseous vascular malformation (VMOS) G
Others
ISSVA classification for vascular anomalies
Back to
overview
some lesions may be associated with thrombocytopenia and/or consumptive coagulopathy see details
clic on G to see genetics
Type Alt
for previous
view
123. Simple vascular malformations IV
Arteriovenous malformations (AVM)
Sporadic
In HHT G
In CM-AVM G
Others
Arteriovenous fistula (AVF) (congenital)
Sporadic
In HHT G
In CM-AVM G
Others
ISSVA classification for vascular anomalies
Back to
overview
Abbreviations used clic on G to see genetics
Type Alt
for previous
view
124. ISSVA classification for vascular anomalies
Combined vascular malformations*
CM + VM capillary-venous malformation CVM
CM + LM capillary-lymphatic malformation CLM
CM + AVM capillary-arteriovenous malformation CAVM
LM + VM lymphatic-venous malformation LVM
CM + LM + VM capillary-lymphatic-venous malformation CLVM
CM + LM + AVM capillary-lymphatic-arteriovenous malformation CLAVM
CM + VM + AVM capillary-venous-arteriovenous malformation CVAVM
CM + LM + VM + AVM capillary-lymphatic-venous-arteriovenous m. CLVAVM
Back to
overview
Abbreviations used
* defined as two or more vascular malformations found in one lesion
Type Alt
for previous
view
125. ISSVA classification for vascular anomalies
Back to
overview
Anomalies of major named vessels
(aka "channel type" or "truncal" vascular malformations)
Affect
lymphatics
veins
arteries
Anomalies of
origin
course
number
length
diameter (aplasia, hypoplasia, stenosis, ectasia / aneurysm)
valves
communication (AVF)
persistence (of embryonal vessel)
Abbreviations used
Type Alt
for previous
view
126. ISSVA classification for vascular anomalies
Back to
overview
Vascular malformations associated with other anomalies
Klippel-Trenaunay syndrome: CM + VM +/- LM + limb overgrowth G
Parkes Weber syndrome: CM + AVF + limb overgrowth G
Servelle-Martorell syndrome: limb VM + bone undergrowth
Sturge-Weber syndrome: facial + leptomeningeal CM + eye anomalies
+/- bone and/or soft tissue overgrowth G
Limb CM + congenital non-progressive limb hypertrophy G
Maffucci syndrome: VM +/- spindle-cell hemangioma + enchondroma G
Macrocephaly - CM (M-CM / MCAP) G
Microcephaly - CM (MICCAP) G
CLOVES syndrome: LM + VM + CM +/- AVM + lipomatous overgrowth G
Proteus syndrome: CM, VM and/or LM + asymmetrical somatic overgrowth G
Bannayan-Riley-Ruvalcaba sd: AVM + VM +macrocephaly, lipomatous overgrowth G
CLAPO syndrome: lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
Abbreviations used clic on G to see genetics
Type Alt
for previous
view
127. Appendix 1
abbreviations used
(excluding gene names)
Back to
overview
AVF arteriovenous fistula
AVM arteriovenous malformation
CAT cutaneovisceral angiomatosis with thrombocytopenia
CAVM capillary arteriovenous malformation
CCM cerebral cavernous malformation
CLAVM capillary lymphatic arteriovenous malformation
CLAPO
lower lip CM + face and neck LM + asymmetry and
partial/generalized overgrowth
CLOVES
congenital lipomatous overgrowth, vascular
malformations, epidermal nevi, skeletal/scoliosis and
spinal abnormalities
CLM capillary lymphatic malformation
CLVAVM capillary lymphatic venous arteriovenous malformation
CLVM capillary lymphatic venous malformation
CM capillary malformation
CM-AVM capillary malformation-arteriovenous malformation
CMTC cutis marmorata telangiectatica congenita
CNS central nervous system
CVAVM capillary venous arteriovenous malformation
CVM capillary venous malformation
DIC disseminated intravascular coagulopathy
FAVA Fibro adipose vascular anomaly
GLA generalized lymphatic anomaly
GSD Gorham-Stout disease
GVM glomuvenous malformation
HHT hereditary hemorrhagic telangiectasia
HI hemangioma of infancy / infantile hemangioma
IH infantile hemangioma / hemangioma of infancy
INR international normalized ratio
JPHT juvenile polyposis hemorrhagic telangiectasia
KHE kaposiform hemangioendothelioma
KLA kaposiform lymphangiomatosis
KMP Kasabach-Merritt phenomenon,
LM lymphatic malformation
LVM lymphatic venous malformation
MCAP megalencephaly-capillary malformation-polymicrogyria
M-CM macrocephaly-capillary malformation
MICCAP microcephaly-capillary malformation
MLT
Multifocal lymphangioendotheliomatosis with
thrombocytopenia
NICH non-involuting congenital hemangioma
PHACE
posterior fossa malformations, hemangioma, arterial
anomalies, cardiovascular anomalies, eye anomalies
PHOST PTEN hamartoma of soft tissue
PILA papillary intralymphatic angioendothelioma
PICH partially involuting congenital hemangioma
RICH rapidly involuting congenital hemangioma
TA tufted angioma
VM venous malformation
VMCM venous malformation cutaneo mucosal
Type Alt
for previous
view
128. Appendix 3
infantile hemangioma
Back to
overview
Pattern
- focal
- multifocal
- segmental
- indeterminate
Different types
- superficial
- deep
- mixed (superficial + deep)
- reticular / abortive / minimal growth
- others
Association with other lesions
PHACE association /
syndrome
Posterior fossa malformations, Hemangioma, Arterial
anomalies, Cardiovascular anomalies, Eye anomalies,
sternal clefting and ⁄ or supraumbilical raphe
LUMBAR (SACRAL,
PELVIS) association /
syndrome
Lower body hemangioma, Urogenital anomalies,
Ulceration, Myelopathy, Bony deformities, Anorectal
malformations, Arterial anomalies, and Renal anomalies
Type Alt
for previous
view
133. No response to Sirolimus
Response to Vincristine –Ticlopidine – Aspirine
and percutaneous biliary diversion
Triana PJ, Lopez Gutierrez JC Pancreatic Kaposiform Hemangioendothelioma Not
Responding to Sirolimus. European Journal of Pediatric Surgery. 2017;5(1).